{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-016519","form_type":"8-K","ticker":"LGVN","cik":"0001721484","company_name":"Longeveron Inc.","filed_at":"2026-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.001386+00:00","generated_at":"2026-05-16T02:48:10.568056+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Longeveron appoints Stephen Willard as CEO; Powell resigns; 50% salary deferral enacted","bullets":["Stephen H. Willard appointed permanent CEO effective Feb 11, 2026; succeeds interim CEO Than Powell who remains in BD role.","Willard receives base salary $500K/yr, deferred to $250K during temporary 50% deferral period for CEO and Executive Chairman.","Initial equity grant: 200K shares, 200K RSUs, 200K stock option; all vest quarterly over four years.","Company implements cost reductions: 50% salary deferral for CEO/Exec Chairman, furloughs, reduced board fees; 50K RSUs to each exec.","Pivotal Phase 2b HLHS trial top-line results expected Q3 2026; FDA guidance that success could support BLA filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-016519","json":"https://secwatch.observer/filing/0001213900-26-016519.json","markdown":"https://secwatch.observer/filing/0001213900-26-016519.md","text":"https://secwatch.observer/filing/0001213900-26-016519.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1721484/000121390026016519/0001213900-26-016519-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1721484/000121390026016519/ea0277101-8k_longeveron.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:48:10.568056+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}